Evidence for systems that carry regulated work.
Source-backed reporting and analysis connected to the companies, capabilities, authorities, and operating domains it affects.
Kivo documents submission structures, content placeholders, a blinded-or-unblinded toggle, tracking spreadsheets, and export to publishing partners or software. A handoff still needs an approved content inventory, artifact-level blinding state, immutable transfer manifest, and receiver reconciliation before it can be treated as complete or appropriately disclosed.
Generis presents CARA as one governed platform spanning regulatory, quality, safety, and clinical processes, with shared records and audit trails. The same underlying record can reduce re-entry, but each configured process still needs intended-use, migration, access, workflow, calculation, report, interface, and exception evidence before the organization can rely on it for regulated work.
EMA says the PLM web-based electronic Application Form becomes mandatory for human Centrally Authorised Product variation submissions on September 1, 2026, with justified technical exceptions for continued interactive-PDF use. Regulatory operations need to preserve the applicable form path, impediment, support evidence, submission package, and receipt outcome as separate controlled facts.
ArisGlobal presents LifeSphere Regulatory as an end-to-end environment for regulatory data, content, submissions, labeling, planning, tracking, and health-authority interactions. Connecting those records can improve oversight, but an incoming question, an outgoing response, a promised action, and completion evidence still need distinct identities, owners, dates, and approval states.
ETQ presents audit management, quality events, nonconformance handling, CAPA, change, and release work in a configurable quality platform. Linking those workflows can reduce handoff loss, but an audit finding, immediate containment, systemic corrective action, and effectiveness conclusion remain different evidence states.
Kneat presents a digital platform for GxP validation requirements, testing, execution, review, traceability, and lifecycle change. An exception can reach a closed workflow state after investigation and planned correction, but the validated record still needs to show whether the affected requirement was retested under the approved conditions and what result was actually observed.
Honeywell describes TrackWise PQR as automating Annual Product Quality Review work and TrackWise QMR as providing near-real-time metrics for management reviews. Connecting both can improve visibility, but a current metric, a periodic product review, and an authorized management conclusion answer different questions.
Ennov presents its Quality Suite as one application for managing and tracking quality documentation, processes, and data, with document management, quality management, and training in the suite. A unified record can make work visible and reviewable, but it does not by itself establish that a configured process was suitable, followed, or effective for its intended regulated use.
Greenlight Guru presents a medical-device platform connecting design controls, risk, product traceability, documents, training, suppliers, quality events, and CAPA. Linked evidence can make a release review reconstructable, but the links do not establish that requirements were met or authorize a device to move forward.
Qualio describes gap analysis, cross-mapped evidence, regulatory monitoring, and quality workflows in one platform. Reusing evidence can reduce duplicate work while each requirement still needs a current scope, implemented process, operating record, qualified review, and defensible conclusion.
Veeva describes a single cloud platform spanning quality assurance, quality control, and training. Connected records can reduce handoff friction without making a document approval, investigation conclusion, laboratory result, and training completion interchangeable.
The July release carries bug fixes and sits inside a broader transition toward structured application data, new MAA forms, and mandatory PLM web-based eAF use for centrally authorised product variations.
The July package refresh adds forward-compatibility samples and revises regional vocabulary, conformance, and transmission materials for a standard FDA already accepts for new applications.
The January transition changes classification and procedure rules for post-authorisation changes, forcing regulatory operations teams to align systems, forms, content, and implementation dates.
